bullish

Takeda: Conservative Guidance Is Not Something to Worry Too Much About..

420 Views12 May 2023 11:32
Takeda's FY03/24 guidance suggests slowdown in earnings due to expiry of Azilva and Vyvanse. Recent new launches have seen strong uptake and the company is being too cautious not to disappoint market
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x